Jpmorgan Chase & Co »

Ngm Biopharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Ngm Biopharmaceuticals (NGM) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Ngm Biopharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ngm Biopharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ngm Biopharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $29k 19k 1.59
2023-12-31 $24k 28k 0.86
2023-09-30 $1.5M 1.4M 1.07
2023-06-30 $1.4M 547k 2.59
2023-03-31 $2.1M 509k 4.08
2022-12-31 $2.8M 567k 5.02
2022-06-30 $7.1M 553k 12.82
2022-03-31 $8.1M 534k 15.25
2021-12-31 $11M 623k 17.78
2021-03-31 $5.1M 175k 29.07
2020-12-31 $5.8M 192k 30.29
2020-09-30 $3.3M 203k 16.11
2020-06-30 $4.3M 218k 19.74
2020-03-31 $0 243k 0.00
2019-12-31 $0 285k 0.00
2019-09-30 $31k 2.2k 13.84
2019-06-30 $27k 1.8k 14.62